Advances in Rheumatoid Arthritis Drugs
(2016)
Advances in Rheumatoid Arthritis Drugs: pp.
-.
Chapter 7
Efficacy and Safety of Pateclizumab (Anti-Lymphotoxin-α) Compared to Adalimumab in Rheumatoid Arthritis: A Head-to-Head Phase 2 Randomized Controlled Study (the ALTARA Study)